Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRecord History now shows a new revision labeled v3.5.3, replacing the previous v3.5.2 entry. This reflects an update to the study record's history metadata on the page.SummaryDifference0.2%

- Check20 days agoChange DetectedNo additions or deletions were provided, indicating no trackable changes to the study record content in this check.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a new revision entry for v3.5.2 and removed the earlier revision v3.5.0 in the record history.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History, updating the list of study record revisions.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history shows that revision v3.4.3 was added and revision v3.4.2 was removed from the version list.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding/operating status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.